UniProt ID | PPARG_HUMAN | |
---|---|---|
UniProt AC | P37231 | |
Protein Name | Peroxisome proliferator-activated receptor gamma | |
Gene Name | PPARG | |
Organism | Homo sapiens (Human). | |
Sequence Length | 505 | |
Subcellular Localization | Nucleus. Cytoplasm. Redistributed from the nucleus to the cytosol through a MAP2K1/MEK1-dependent manner. NOCT enhances its nuclear translocation. | |
Protein Description | Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut homeostasis by suppressing NF-kappa-B-mediated proinflammatory responses. Plays a role in the regulation of cardiovascular circadian rhythms by regulating the transcription of ARNTL/BMAL1 in the blood vessels (By similarity).; (Microbial infection) Upon treatment with M.tuberculosis or its lipoprotein LpqH, phosphorylation of MAPK p38 and IL-6 production are modulated, probably via this protein.. | |
Protein Sequence | MGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDLSVMEDHSHSFDIKPFTTVDFSSISTPHYEDIPFTRTDPVVADYKYDLKLQEYQSAIKVEPASPPYYSEKTQLYNKPHEEPSNSLMAIECRVCGDKASGFHYGVHACEGCKGFFRRTIRLKLIYDRCDLNCRIHKKSRNKCQYCRFQKCLAVGMSHNAIRFGRMPQAEKEKLLAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
63 | Sumoylation | HSHSFDIKPFTTVDF CCCCCCCCCCEEECH | 35.60 | - | |
74 (in isoform 2) | Phosphorylation | - | 37.52 | - | |
78 | Phosphorylation | SSISTPHYEDIPFTR HHCCCCCCCCCCCCC | 19.25 | - | |
79 (in isoform 2) | Sumoylation | - | 46.56 | - | |
84 (in isoform 3) | Phosphorylation | - | 27.57 | - | |
84 | O-linked_Glycosylation | HYEDIPFTRTDPVVA CCCCCCCCCCCCCEE | 27.57 | UniProtKB CARBOHYD | |
95 | Phosphorylation | PVVADYKYDLKLQEY CCEEECCEEEECHHH | 21.93 | - | |
102 | Phosphorylation | YDLKLQEYQSAIKVE EEEECHHHHHCCCCC | 8.53 | 25690035 | |
104 | Phosphorylation | LKLQEYQSAIKVEPA EECHHHHHCCCCCCC | 30.93 | 25690035 | |
107 | Sumoylation | QEYQSAIKVEPASPP HHHHHCCCCCCCCCC | 40.02 | - | |
107 | Sumoylation | QEYQSAIKVEPASPP HHHHHCCCCCCCCCC | 40.02 | - | |
112 | Phosphorylation | AIKVEPASPPYYSEK CCCCCCCCCCCCCHH | 36.80 | 16574647 | |
115 | Phosphorylation | VEPASPPYYSEKTQL CCCCCCCCCCHHHCC | 24.02 | 28450419 | |
116 | Phosphorylation | EPASPPYYSEKTQLY CCCCCCCCCHHHCCC | 19.00 | 28450419 | |
117 | Phosphorylation | PASPPYYSEKTQLYN CCCCCCCCHHHCCCC | 27.12 | 28450419 | |
123 | Phosphorylation | YSEKTQLYNKPHEEP CCHHHCCCCCCCCCC | 16.01 | 27642862 | |
184 | Ubiquitination | DLNCRIHKKSRNKCQ CCCCEEEHHCCCCCC | 50.50 | - | |
185 | Ubiquitination | LNCRIHKKSRNKCQY CCCEEEHHCCCCCCC | 40.25 | - | |
245 (in isoform 2) | Phosphorylation | - | 24.82 | - | |
269 | Phosphorylation | RAILTGKTTDKSPFV HHHHCCCCCCCCCEE | 41.39 | 18452278 | |
273 | Phosphorylation | TGKTTDKSPFVIYDM CCCCCCCCCEEEEEC | 26.78 | 20651683 | |
364 | Sumoylation | MLASLMNKDGVLISE HHHHHCCCCCCEEEC | 41.72 | - | |
367 (in isoform 2) | Sumoylation | - | 6.51 | - | |
395 | Sumoylation | FGDFMEPKFEFAVKF CCCCCCCCCEEEEEE | 44.19 | - | |
395 | Sumoylation | FGDFMEPKFEFAVKF CCCCCCCCCEEEEEE | 44.19 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
74 | Y | Phosphorylation | Kinase | EGFR | P00533 | PSP |
78 | Y | Phosphorylation | Kinase | ABL | P00519 | PSP |
102 | Y | Phosphorylation | Kinase | ABL | P00519 | PSP |
112 | S | Phosphorylation | Kinase | CDK9 | P50750 | PSP |
112 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
112 | S | Phosphorylation | Kinase | MAPK8 | P45983 | GPS |
112 | S | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
273 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | NEDD4 | P46934 | PMID:23549616 |
- | K | Ubiquitination | E3 ubiquitin ligase | SIAH2 | O43255 | PMID:22294748 |
- | K | Ubiquitination | E3 ubiquitin ligase | AHR | P35869 | PMID:31653699 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
112 | S | Phosphorylation |
| 23186163 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PPARG_HUMAN !! |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
Note=Defects in PPARG can lead to type 2 insulin-resistant diabetes and hyptertension. PPARG mutations may be associated with colon cancer. | |
601665 | |
604367 | Lipodystrophy, familial partial, 3 (FPLD3) |
137800 | Glioma 1 (GLM1) |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB01014 | Balsalazide |
DB01393 | Bezafibrate |
DB01067 | Glipizide |
DB01050 | Ibuprofen |
DB00159 | Icosapent |
DB00328 | Indomethacin |
DB00244 | Mesalazine |
DB01252 | Mitiglinide |
DB00731 | Nateglinide |
DB01132 | Pioglitazone |
DB00912 | Repaglinide |
DB00412 | Rosiglitazone |
DB00795 | Sulfasalazine |
DB00966 | Telmisartan |
loading...